Recall Enforment Report D-0324-2021

Drug Recall Enforcement Report Class II voluntary initiated by Apotex Corp., originally initiated on 03-31-2021 for the product Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0 The product was recalled due to cross contamination with other product: product is being recalled due to trace amounts of quetiapine fumarate. The product was distributed nationwide and the recall is currently ongoing.

Field Name	Field Value
Event ID	87648 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number	D-0324-2021 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification	Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern	Nationwide within the United States What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description	Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Reason For Recall	Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate What is the Reason for Recall? Information describing how the product is defective.
Product Quantity	55620 bottles Product Quantity The amount of product subject to recall.
Voluntary Mandated	Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date	04-14-2021
Recall Initiation Date	03-31-2021 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall.
Initial Firm Notification	Press Release Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type	Drugs
Recalling Firm	Apotex Corp.
Code Info	Lot #: RX1662, RX1663, RX1664 Exp. 11/2022 Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages	60505-3927-3; 60505-3927-1; 60505-3927-8; 60505-3928-3; 60505-3928-1; 60505-3928-8; 60505-3929-3; 60505-3929-1; 60505-3929-8; 60505-3930-3; 60505-3930-1; 60505-3930-8
Status	Ongoing

Recalled Products